Nobel Laureates Explore Innate Immunity as Disease Prevention Strategy
January 4, 2012
In recent years a remarkable evolutionary conservation of innate immune mechanisms has become apparent between flies, plants, mice and humans. Each of these species uses similar receptors to detect microbes. Therapeutic targeting of toll-like receptors for infectious and inflammatory disease and cancer and crop engineering of these receptors for resistance to infection is now a reality.
The faculty of the Center for Comparative Medicine invite interested members of the public to the symposium, "The Evolution of Common Molecular Pathways Underlying Innate Immunity," Wednesday, January 25, 2012, 1:00 p.m. - 5:00 p.m. at the UC Davis Conference Center, Davis, California.
Two Nobel laureates and a pioneer investigator from UC Davis will speak on the topic of innate immunity and microbe receptors:
- Plants, Dr. Pamela Ronald, UC Davis
- Drosophila, Dr. Jules Hoffmann, 2011 Nobel Laureate in Physiology or Medicine, University of Strasbourg
- Mice, Dr. Bruce Beutler, 2011 Nobel Laureate in Physiology or Medicine, University of Texas Southwestern Medical Center.
The role of these receptors in driving inflammatory diseases of humans will be summarized by Dr. Luke O’Neill, Trinity College of Dublin.
This symposium is free of charge but attendees must register to attend.
Registration information: http://www.cevs.ucdavis.edu/confreg/index.cfm?confid=565
For more information, please contact Anita Moore, Center for Comparative Medicine, 530-752-1245, email@example.com.